SIRT1 - An Anti-Inflammatory Pathway at the Crossroads Between Metabolic Disease and Atherosclerosis

E-ISSN： 1875-6212|10|6|693-696

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.10, Iss.6, 2012-11, pp. : 693-696

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-correlation between longevity gene SirT1 and Notch signaling in ascending aorta biopsies from patients with bicuspid aortic valve disease

By Sciacca Sergio

Heart and Vessels, Vol. 28, Iss. 2, 2013-03 ,pp. : 268-275

Springer Publishing Company

Access to resources Recommend Favorite

Anti-inflammatory and anti-atherogenic role of BMP receptor II in atherosclerosis

By Simic Tatjana

Future Cardiology, Vol. 9, Iss. 5, 2013-09 ,pp. : 619-622

Future Medicine

Access to resources Recommend Favorite

The Role of the Stress-Related Anti-Inflammatory Hormones ACTH and Cortisol in Atherosclerosis

Current Vascular Pharmacology, Vol. 8, Iss. 4, 2010-07 ,pp. : 517-525

Bentham Science Publishers

Access to resources Recommend Favorite

A Review of Sirt1 and Sirt1 Modulators in Cardiovascular and Metabolic Diseases

Recent Patents on Cardiovascular Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. : 156-164

Bentham Science Publishers

Access to resources Recommend Favorite

Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease

Neuroepidemiology, Vol. 28, Iss. 4, 2007-09 ,pp. : 193-196

Karger

Access to resources Recommend Favorite